Table of Contents Author Guidelines Submit a Manuscript
Advances in Orthopedics
Volume 2018, Article ID 4791214, 8 pages
https://doi.org/10.1155/2018/4791214
Research Article

Standardised Warfarin Reversal Expedites Time to Theatre for Fractured Neck of Femur Surgery and Improves Mortality Rates: A Matched Cohort Study

Department of Trauma and Orthopaedics, Royal Stoke University Hospital, Stoke-on-Trent, Staffordshire, UK

Correspondence should be addressed to Matthew J. Walker; moc.liamelgoog@7891reklawnhojwehttam

Received 16 March 2018; Revised 23 September 2018; Accepted 30 September 2018; Published 21 October 2018

Guest Editor: Sumon Nandi

Copyright © 2018 Thomas S. Moores et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Marzolini and H. A. Wynne, “Should patients manage their own oral anticoagulation therapy?” Reviews in Clinical Gerontology, vol. 12, no. 4, pp. 275–281, 2003. View at Google Scholar · View at Scopus
  2. M. Sudlow, R. Thomson, B. Thwaites, H. Rodgers, and R. A. Kenny, “Prevalence of atrial fibrillation and eligibility for anticoagulants in the community,” The Lancet, vol. 352, no. 9135, pp. 1167–1171, 1998. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Ashouri, W. Al-jundi, A. Patel, and J. Mangwani, “Management of Warfarin Anticoagulation in Patients with Fractured Neck of Femur,” Haem, p. 194628, 2011. View at Google Scholar
  4. National Institute for Health and Care Excellence, “Hip Fracture: The management of hip fracture in adults (2011),” CG124. London. (date last accessed November 2014) https://www.nice.org.uk/guidance/CG124.
  5. Health Episode Statistics. Primary diagnosis: 4 character, S72.0–S72.2. (date last accessed 16 August 2014) http://www.hesonline.org.uk/Ease/servlet/ContentServer?siteID=1937&categoryID=214.
  6. C. P. Bretherton and M. J. Parker, “Early surgery for patients with a fracture of the hip decreases 30 day mortality,” The Bone & Joint Journal, vol. 97, no. B(1), pp. 104–108, 2015. View at Google Scholar
  7. T. Shiga, Z. Wajima, and Y. Ohe, “Is operative delay associated with increased mortality of hip fracture patients? Systematic review, meta-analysis, and meta-regression,” Canadian Journal of Anesthesia, vol. 55, no. 3, pp. 146–154, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Moja, A. Piatti, V. Pecoraro et al., “Timing matters in hip fracture surgery: patients operated within 48 hours have better outcomes. A meta-analysis and meta-regression of over 190,000 patients,” PLoS ONE, vol. 7, no. 10, Article ID e46175, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. T. S. Moores, A. Beaven, A. E. Cattell, C. Baker, and P. J. Roberts, “Preoperative warfarin reversal for early hip fracture surgery,” Journal of Orthopaedic Surgery, vol. 23, no. 1, pp. 33–36, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Leonidou, R. Rallan, N. Cox, J. Pagkalos, and J. Luscombe, “Comparison of different warfarin reversal protocols on surgical delay and complication rate in hip fracture patients.,” Journal of Orthopaedic Surgery (Hong Kong), vol. 21, no. 2, pp. 142–145, 2013. View at Publisher · View at Google Scholar · View at Scopus
  11. Department of Health Payment by Results team, “Best Practice Tariff,” (last accessed December 2014). http://www.dh.gov.uk/health/2012/02/confirmation-pbr-arrangements/.
  12. Royal College of Physicians, “National Hip Fracture Database annual report 2014,” London: RCP, 2014. http://www.nhfd.co.uk/20/hipfractureR.nsf/vwcontent/2014reportPDFs/$file/NHFD2014ExtendedReport.pdf?OpenElement.
  13. D. B. Chatterton, T. S. Moores, A. Cattell et al., “Cause of death and factors associated with early in-hospital mortality after hip fracture: An eight-year retrospective cohort study of 4426 patients,” The Bone & Joint Journal, vol. 97B, pp. 246–251, 2015. View at Google Scholar
  14. D. S. Whitlon, J. A. Sadowski, J. W. Suttie, and J. A. Sadowski, “Mechanism of Coumarin Action: Significance of Vitamin K Epoxide Reductase Inhibition,” Biochemistry, vol. 17, no. 8, pp. 1371–1377, 1978. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Bansal and D. K. Watson, “Surgical delay in acute admissions on warfarin: Are we doing enough?” International Journal of Clinical Practice, vol. 59, no. 11, pp. 1283–1288, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. R. H. White, T. McKittrick, R. Hutchinson, and J. Twitchell, “Temporary discontinuation of warfarin therapy: Changes in the international normalized ratio,” Annals of Internal Medicine, vol. 122, no. 1, pp. 40–42, 1995. View at Publisher · View at Google Scholar · View at Scopus
  17. M. Al-Rashid and M. J. Parker, “Anticoagulation management in hip fracture patients on warfarin,” Injury, vol. 59, no. 11, pp. 1283–1288, 2005. View at Google Scholar
  18. British Committee for Standards in Haematology, “BTTF. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant,” The British Society for Haematology; 2004.
  19. H. G. Watson, T. Baglin, S. L. Laidlaw, M. Makris, and F. E. Preston, “A comparison of the efficacy and rate of response to oral and intravenous Vitamin K in reversal of over-anticoagulation with warfarin,” British Journal of Haematology, vol. 115, no. 1, pp. 145–149, 2001. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Ansell, J. Hirsh, E. Hylek, A. Jacobson, M. Crowther, and G. Palareti, “Pharmacology and management of the vitamin k antagonists: american college of chest physicians evidence-based clinical practice guidelines,” CHEST, vol. 133, no. 6, pp. 160–198, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. T. T. Horlocker, D. J. Wedel, H. Benzon et al., “Regional Anesthesia in the Anticoagulated Patient,” Regional Anesthesia and Pain Medicine, vol. 28, no. 3, pp. 172–197, 2003. View at Publisher · View at Google Scholar
  22. C. Kearon and J. Hirsh, “Management of anticoagulation before and after elective surgery,” The New England Journal of Medicine, vol. 336, no. 21, pp. 1506–1511, 1997. View at Google Scholar
  23. C. P. Charalambous, S. Yarwood, C. Paschalides et al., “Factors delaying surgical treatment of hip fractures in elderly patients,” Annals of the Royal College of Surgeons of England, vol. 85, pp. 117–119, 2003. View at Google Scholar
  24. M. P. Fantini, G. Fabbri, M. Laus et al., “Determinants of surgical delay for hip fracture,” The Surgeon, vol. 9, no. 3, pp. 130–134, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. Scottish Intercollegiate Guidelines Network, “Guideline 111. Management of hip fracture in older people. A national clinical guideline,” 2009. (last accessed December 2014) https://www.sign.ac.uk/assets/sign111.pdf.
  26. C. G. Moran, R. T. Wenn, M. Sikand, and A. M. Taylor, “Early Mortality after hip fracture: is delay before surgery important?” Journal of Bone and Joint Surgery, vol. 87, no. 3, pp. 483–498, 2005. View at Google Scholar
  27. J. E. Lawrence, D. M. Fountain, D. J. Cundall-Curry, and A. D. Carrothers, “Do Patients Taking Warfarin Experience Delays to Theatre, Longer Hospital Stay, and Poorer Survival After Hip Fracture?” Clinical Orthopaedics and Related Research, vol. 475, no. 1, pp. 273–279, 2017. View at Publisher · View at Google Scholar · View at Scopus
  28. World Health Organisation, “International Statistical Classification of Diseases and Related Health Problems 10th Revision,” (date last accessed 16 August 2014) http://apps.who.int/classifications/icd10/browse/2010/en.
  29. P. C. Austin, “An introduction to propensity score methods for reducing the effects of confounding in observational studies,” Multivariate Behavioral Research, vol. 46, no. 3, pp. 399–424, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. R Core Team, “R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria, 2013,” (accessed December 2014) http://www.R-project.org/.
  31. F. Hu, C. Jiang, J. Shen, P. Tang, and Y. Wang, “Preoperative predictors for mortality following hip fracture surgery: a systematic review and meta-analysis,” Injury, vol. 43, no. 6, pp. 676–685, 2012. View at Publisher · View at Google Scholar · View at Scopus
  32. Office for National Statistics, “Mortality in England and Wales: Average Life Span,” Published December 2012. (date last accessed December 2014) http://www.ons.gov.uk/ons/dcp171776_292196.pdf.
  33. S. A. Frost, N. D. Nguyen, J. R. Center et al., “Excess mortality attribuitable to hip fracture: a relative Survival analysis,” Bone, vol. 56, pp. 23–29, 2013. View at Google Scholar
  34. S. MacLennan and L. M. Williamson, “Risks of fresh frozen plasma and platelets,” The Journal of Trauma, vol. 60, pp. S46–S50, 2006. View at Google Scholar
  35. S. Travis, R. Wray, and K. Harrison, “Perioperative anticoagulant control,” British Journal of Surgery, vol. 76, no. 11, pp. 1107-1108, 1989. View at Publisher · View at Google Scholar · View at Scopus
  36. C. L. Daugaard, H. L. Jorgensen, T. Riis, J. B. Lauritzen, B. R. Duus, and S. Van Der Mark, “Is mortality after hip fracture associated with surgical delay or admission during weekends and public holidays? A retrospective study of 38,020 patients,” Acta Orthopaedica, vol. 83, no. 6, pp. 609–613, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Balasegaram, A. Majeed, and H. Fitz-Clarence, “Trends in hospital admissions for fractures of the hip and femur in England, 1989-1990 to 1997-1998,” Journal of Public Health, vol. 23, no. 1, pp. 11–17, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. E. M. Burns, E. Rigby, R. Mamidanna et al., “Systematic review of discharge coding accuracy,” Journal of Public Health, vol. 34, no. 1, pp. 138–148, 2012. View at Publisher · View at Google Scholar · View at Scopus